This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of buprenorphine injection (pain relief): A Synthesis of Findings from 26 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of buprenorphine injection (pain relief): A Synthesis of Findings from 26 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main research findings

Buprenorphine is a widely used analgesic for the relief of postoperative pain in rats. 16 , 12 , 21 , 22 , 24 , 20 , 11 , 4 , 18 , 10 , 17 , 25 , 14 , 3 , 9 , 7 , , 23 , 5 , 8 , 2 , 19 , 6 , 15 , 1 , 13 . Studies have shown that buprenorphine can provide pain relief in patients with chronic pain conditions, such as cancer pain. 10 , 8 . Buprenorphine has been shown to be effective in combination with other analgesics, such as morphine, for postoperative pain relief. 21 , 17 . Some studies have suggested that buprenorphine may have a longer duration of action than other analgesics. 12 , 21 , 9 .

Benefits and risks

Benefit summary

Buprenorphine is a potent opioid analgesic acting on all four opioid receptors: it is an agonist on the mu-, the delta, and the ORL-1 receptors. 5 . Buprenorphine has a number of active metabolites with different effects on the four opioid receptors; all except the norbup-3-glu are analgesic. 5 . Buprenorphine itself is not a respiratory depressant or sedative, but some of its active metabolites are. 5 . Buprenorphine and its active metabolites are not excreted by the kidney. Therefore buprenorphine may be used in patients with advanced renal failure. 5 . Buprenorphine has a slow onset and a long offset. These properties are advantageous, except sometimes when treating severe acute pain. 5 . Buprenorphine is well suited for treatment of chronic pain, especially chronic neuropathic pain and cancer pain. 5 . Buprenorphine is also used for opioid abuse rehabilitation. 5 .

Risk summary

Buprenorphine is a mu-agonist, which may induce or maintain opioid addiction. 5 . Buprenorphine may cause side effects, such as weight gain, constipation, and nausea. 10 . Buprenorphine can also interact with other medications, so it is important to talk to your doctor about any medications you are taking before starting buprenorphine. 5 .

Comparison between studies

Commonalities of studies

Buprenorphine has been studied in a variety of animal models, including rats, mice, and ponies. 16 , 12 , 21 , 22 , 24 , 20 , 14 , 9 , 7 , 1 . Buprenorphine has been administered via a variety of routes, including intravenous, subcutaneous, intrathecal, and epidural. 20 , 4 , 17 , 8 . The studies generally found that buprenorphine was effective in reducing postoperative pain. 12 , 21 , 14 , 7 , 8 .

Differences between studies

The effectiveness of buprenorphine for pain relief may vary depending on the dose, route of administration, and the specific pain model. 21 , 20 , 4 , 8 . Some studies have found that buprenorphine can delay recovery after surgery. 16 . Buprenorphine may also cause side effects, such as changes in behavior and weight. 22 , 9 , 4 .

Consistency and contradictions of results

The research on buprenorphine has shown some consistency in its effects, but there are also some contradictions. 16 , 12 , 21 , 22 , 24 , 20 , 11 , 4 , 18 , 10 , 17 , 25 , 14 , 3 , 9 , 7 , , 23 , 5 , 8 , 2 , 19 , 6 , 15 , 1 , 13 . While buprenorphine is generally effective for pain relief, some studies have suggested that it may not be as effective as other analgesics. 14 , 23 . The effectiveness of buprenorphine may also be affected by the dose and route of administration. 21 , 20 , 4 , 8 .

Considerations for real-world application

Buprenorphine is a potent analgesic that can be effective for pain relief, but it is important to be aware of the potential risks. 16 , 22 , 9 , 4 . It is important to discuss the risks and benefits of buprenorphine with your doctor before starting treatment. 21 , 20 , 4 , 8 . Buprenorphine is a controlled substance, so it is important to follow your doctor's instructions carefully. 5 .

Limitations of current research

The research on buprenorphine is still ongoing, and there are many unanswered questions. 16 , 12 , 21 , 22 , 24 , 20 , 11 , 4 , 18 , 10 , 17 , 25 , 14 , 3 , 9 , 7 , , 23 , 5 , 8 , 2 , 19 , 6 , 15 , 1 , 13 . More research is needed to determine the long-term effects of buprenorphine. 16 . More research is needed to determine the best way to use buprenorphine for pain relief. 21 , 20 , 4 , 8 .

Future research directions

Future research should focus on determining the long-term effects of buprenorphine on recovery after surgery. 16 . Future research should also focus on determining the best way to use buprenorphine for pain relief, including the optimal dose, route of administration, and combination with other analgesics. 21 , 20 , 4 , 8 . It is also important to investigate the potential for buprenorphine to cause side effects, especially in patients with chronic pain. 10 , 8 .

Conclusion

Buprenorphine is a potent analgesic that can be effective for pain relief. 16 , 22 , 9 , 4 . However, it is important to be aware of the potential risks associated with buprenorphine, such as addiction and side effects. 21 , 20 , 4 , 8 . It is important to discuss the risks and benefits of buprenorphine with your doctor before starting treatment. 5 .


Literature analysis of 26 papers
Positive Content
22
Neutral Content
2
Negative Content
2
Article Type
5
2
2
6
26

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Hebrew


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.